Invo Bioscience Inc (INVO)

$0.83 -0.03 (-2.91%)
Market Cap 3.17M
Revenue (ttm) 3.02M
Net Income (ttm) -8.03M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 125,200
Avg Vol 1,316,252
Day's Range N/A - N/A
Shares Out 3.81M
Stochastic %K 26%
Beta 1.43
Analysts Hold
Price Target $2.00
PennyScam
PennyScam Aug. 22 at 7:06 AM
$INVO Pretty sure we need the clinical results before any financing comes. The dots in the earlier presentation show later in the year. So maybe we’ll see some results in early November. Ck
1 · Reply
PennyScam
PennyScam Aug. 21 at 3:25 PM
$INVO I noticed that Bruce. Did you guys happen to notice who was attending? Interesting John Hurt from Atley is there. Same goes for Astra Zeneca. Saw that name amongst all the other joes. Interesting how these companies spanning precisely the manufacturing, isotope, clinical and commercialization infrastructure are what Naya needs. It’s great to see Astra Zeneca representative at this meeting, specifically the Head of Radioconjugate Manufacturing and Development. Nice stuff. Ck
0 · Reply
bruceleeboy
bruceleeboy Aug. 21 at 2:07 PM
$INVO $IVF Wednesday 16th September 2026. Why 2026 Is the Year the Gap Between Clinical Ambition & Operational Capacity Must Begin to Close https://targeted-radiopharma-supplychain-manufacturing.com/speaker/daniel-teper/
3 · Reply
ChuckyNorris
ChuckyNorris Aug. 17 at 8:34 PM
$INVO pump to $2.X 🤑🤑🤑🤑
1 · Reply
PennyScam
PennyScam Aug. 17 at 7:18 PM
$INVO Don’t forget Pfizer has that cliff as well. Everything looks good. 🤔 . Ck
2 · Reply
PennyScam
PennyScam Aug. 17 at 7:16 PM
$INVO I still would like for Astra to let its true feelings show. I think a Pfizer and BMS deal is doable. In today’s landscape, anything is possible. What’s better than a duo. A trio. All for one. All for love. What a merger it would be. Enjoy. Ck https://youtu.be/ofA3URC1wyk?si=MeURc9zwQUXUZD8m
0 · Reply
PennyScam
PennyScam Aug. 17 at 4:46 PM
$INVO Another thing Loxxx. Don’t think for one second that Blackrock wasn’t all knowing in that deal. I think they need to forget the markets ignorance and wild euphoria Ibiza trading type thinking. Fink needs to walk in there and tell them to stick with the plan to graze off the market’s speculation craze but then eventually pull the trigger and lock in those real revenues. Buddy. That’s just my goofy opinion. Can’t be too serious here. It’s all a show to me. It’s a joke right now. I like real money and others don’t. I’m boring. Sorry. It’s just too cuckoo for me. I love crazy people. They make me feel normal. What do we know right. 😂 At this stage, certain figures in certain institutions are just sitting in a room pulling the levers. Just saying. Ck
0 · Reply
PennyScam
PennyScam Aug. 17 at 4:48 AM
$INVO Astra should just add BMS. Lock in that annual revenue 80 billion mark Astra’s been claiming it will make. Ck
0 · Reply
PennyScam
PennyScam Aug. 16 at 5:25 AM
$INVO We’ve got a few capital clusters….ck Cluster 1 - Immune/Cytovia legacy Daniel Teper, Daniel Kazado, Pint Pharma, historical Immune assets/shareholders. Cluster 2 - Cytovia cell-therapy/China capital Cellectis, TF Capital, YF Capital, BioTrack, Ruihua, TG Sino-Dragon/ Tigermed, CytoLynx. Cluster 3 — NAYA public-company financing Five Narrow Lane/Hammer/Rabinowitz, Armistice/Steven Boyd, GreenBlock, Decathlon.
0 · Reply
PennyScam
PennyScam Aug. 16 at 3:56 AM
$INVO People might enjoy this. CK https://cerncourier.com/the-age-of-the-blockbuster-scale-radiopharmaceutical/
0 · Reply
Latest News on INVO
No data available.
PennyScam
PennyScam Aug. 22 at 7:06 AM
$INVO Pretty sure we need the clinical results before any financing comes. The dots in the earlier presentation show later in the year. So maybe we’ll see some results in early November. Ck
1 · Reply
PennyScam
PennyScam Aug. 21 at 3:25 PM
$INVO I noticed that Bruce. Did you guys happen to notice who was attending? Interesting John Hurt from Atley is there. Same goes for Astra Zeneca. Saw that name amongst all the other joes. Interesting how these companies spanning precisely the manufacturing, isotope, clinical and commercialization infrastructure are what Naya needs. It’s great to see Astra Zeneca representative at this meeting, specifically the Head of Radioconjugate Manufacturing and Development. Nice stuff. Ck
0 · Reply
bruceleeboy
bruceleeboy Aug. 21 at 2:07 PM
$INVO $IVF Wednesday 16th September 2026. Why 2026 Is the Year the Gap Between Clinical Ambition & Operational Capacity Must Begin to Close https://targeted-radiopharma-supplychain-manufacturing.com/speaker/daniel-teper/
3 · Reply
ChuckyNorris
ChuckyNorris Aug. 17 at 8:34 PM
$INVO pump to $2.X 🤑🤑🤑🤑
1 · Reply
PennyScam
PennyScam Aug. 17 at 7:18 PM
$INVO Don’t forget Pfizer has that cliff as well. Everything looks good. 🤔 . Ck
2 · Reply
PennyScam
PennyScam Aug. 17 at 7:16 PM
$INVO I still would like for Astra to let its true feelings show. I think a Pfizer and BMS deal is doable. In today’s landscape, anything is possible. What’s better than a duo. A trio. All for one. All for love. What a merger it would be. Enjoy. Ck https://youtu.be/ofA3URC1wyk?si=MeURc9zwQUXUZD8m
0 · Reply
PennyScam
PennyScam Aug. 17 at 4:46 PM
$INVO Another thing Loxxx. Don’t think for one second that Blackrock wasn’t all knowing in that deal. I think they need to forget the markets ignorance and wild euphoria Ibiza trading type thinking. Fink needs to walk in there and tell them to stick with the plan to graze off the market’s speculation craze but then eventually pull the trigger and lock in those real revenues. Buddy. That’s just my goofy opinion. Can’t be too serious here. It’s all a show to me. It’s a joke right now. I like real money and others don’t. I’m boring. Sorry. It’s just too cuckoo for me. I love crazy people. They make me feel normal. What do we know right. 😂 At this stage, certain figures in certain institutions are just sitting in a room pulling the levers. Just saying. Ck
0 · Reply
PennyScam
PennyScam Aug. 17 at 4:48 AM
$INVO Astra should just add BMS. Lock in that annual revenue 80 billion mark Astra’s been claiming it will make. Ck
0 · Reply
PennyScam
PennyScam Aug. 16 at 5:25 AM
$INVO We’ve got a few capital clusters….ck Cluster 1 - Immune/Cytovia legacy Daniel Teper, Daniel Kazado, Pint Pharma, historical Immune assets/shareholders. Cluster 2 - Cytovia cell-therapy/China capital Cellectis, TF Capital, YF Capital, BioTrack, Ruihua, TG Sino-Dragon/ Tigermed, CytoLynx. Cluster 3 — NAYA public-company financing Five Narrow Lane/Hammer/Rabinowitz, Armistice/Steven Boyd, GreenBlock, Decathlon.
0 · Reply
PennyScam
PennyScam Aug. 16 at 3:56 AM
$INVO People might enjoy this. CK https://cerncourier.com/the-age-of-the-blockbuster-scale-radiopharmaceutical/
0 · Reply
PennyScam
PennyScam Aug. 16 at 2:46 AM
$INVO Who knows Rk. I believe nothing I read anymore. I’m pretty sure the system is air tight with AZN. When the time comes, they will speak. I just want my shares. AstraZeneca itself still has not publicly confirmed that it was negotiating a merger with Bristol Myers Squibb. Check it out. They haven’t. Bristol Myers hasn’t confirmed it either. Reuters reported on August 5 that a senior source close to the matter flatly disputed the earlier reports, saying there was no deal and no current discussions; a second source also said negotiations weren’t active. Both companies declined to comment officially. Who knows. Not me. Obviously lots of people believe they know the real truth based on no factual information. Hilarious. Ck
1 · Reply
rlkloehn
rlkloehn Aug. 15 at 10:59 PM
$INVO As Paul Harvey would say, the rest of the story.. https://www.linkedin.com/posts/robert-siegmund_astrazeneca-bristol-myers-squibb-the-400bn-share-7493648875543613441-F4eg/?utm_source=share&utm_medium=member_ios&rcm=ACoAAF-Iu-0Br2vbs8MA5ZcTEtcSRu6s-HTVNwc
1 · Reply
PennyScam
PennyScam Aug. 15 at 3:19 PM
$INVO Any ways. Ck
0 · Reply
PennyScam
PennyScam Aug. 15 at 3:14 PM
$INVO So am I supposed to be excited about this uptick. I’m not…..Ck
0 · Reply
PennyScam
PennyScam Aug. 15 at 3:11 PM
$INVO I don’t know people. This is getting crazy. Ck
0 · Reply
PennyScam
PennyScam Aug. 15 at 3:08 PM
$INVO anyone notice…..Ck The principal is: $4.803M while INVO’s estimated fair value is: $5.169M That’s roughly $366,000 above principal.
0 · Reply
PennyScam
PennyScam Aug. 14 at 7:40 PM
$INVO “On August 14, 2026, Armistice Capital and Steven Boyd filed Schedule 13G/A Amendment No. 2 for INVO Fertility. The filing reports beneficial ownership of 120,537 INVO shares, or 4.99%, as of June 30, 2026.” Reduced position?. Ok……Ck
0 · Reply
PennyScam
PennyScam Aug. 14 at 5:26 PM
$INVO You have Bayer also in there doing their supply deal with 225. I don’t know about you folk but that Ionetix group looks particularly good to me. Just saying. Ck
0 · Reply
PennyScam
PennyScam Aug. 14 at 4:52 PM
$INVO Ionetix management says its existing cash and recent financing are not sufficient to fund operations for the next 12 months, creating substantial going-concern uncertainty and a need for additional capital. That matters for the NAYA relationship because IONETIX is the company NAYA selected for its U.S. At-211 production and supply network…….. I’m seeing some closeted circle jerking here…..Ck
1 · Reply
rlkloehn
rlkloehn Aug. 14 at 4:41 AM
$INVO Naya Therapeutics Inc. was incorporated as Stock Corporation on 14 January 2025, with registered address at "1200 BRICKELL AVENUE, SUITE 1960, MIAMI, FL 33131". The company current operation state is Active . The director the company include: "ERIN HAGGERTY", "CONNIE MIX", "BARBARA BAINE", "MAI YANG", "ALEX GONZALES", "CHRISTEN VINNOLA", "BEE VANG", "AMBER SMYTH", "EMMA HERNANDEZ", . The agent name of this company is: COGENCY GLOBAL INC. Nonfiction Laboratories Inc. was incorporated as Stock Corporation on 17 December 2024, with registered address at "953 INDIANA STREET, SAN FRANCISCO, CA 94107". The company current operation state is Active . The director the company include: "ERIN HAGGERTY", "CONNIE MIX", "BARBARA BAINE", "MAI YANG", "ALEX GONZALES", "CHRISTEN VINNOLA", "BEE VANG", "AMBER SMYTH", "EMMA HERNANDEZ", . The agent name of this company is: COGENCY GLOBAL INC.
1 · Reply
rlkloehn
rlkloehn Aug. 14 at 2:27 AM
$INVO https://www.linkedin.com/posts/maryam-daneshpour_the-bms-megadeal-may-be-dead-astrazeneca-share-7493646045202194432-Wtp2/?utm_source=share&utm_medium=member_ios&rcm=ACoAAF-Iu-0Br2vbs8MA5ZcTEtcSRu6s-HTVNwc
0 · Reply
PennyScam
PennyScam Aug. 12 at 2:23 PM
$INVO 🫡
0 · Reply